CAS号:488832-69-5
品名:伊利司莫elesclomol
中文别名:丙二酸-1,3-二[2-甲基-2-(苯基硫酮甲基)酰肼];
英文别名:STA-4783;1-N',3-N'-bis(benzenecarbonothioyl)-1-N',3-N'-dimethylpropanedihydrazide;Elesclomol;N-malonyl-bis(N'-thiobenzoyl-N'-methylhydrazide);
分子式:C19H20N4O2S2
分子量:400.518
精确质量:400.103
Psa:128.86
MDL号:MFCD12911784
密度:1.313
折射率:1.667
简介:Elesclomol(INN,codenamedSTA-4783)isadrugthattriggersapoptosis(programmedcelldeath)incancercells.ItisbeingdevelopedbySyntaPharmaceuticalsandGlaxoSmithKlineasachemotherapyadjuvant,andhasreceivedbothfasttrackandorphandrugstatusfromtheU.S.FoodandDrugAdministrationforthetreatmentofmetastaticmelanoma.SyntaPharmaceuticalsannouncedonFebruary26,2009thesuspensionofallclinicaltrialsinvolvingElesclomolduetosafetyconcerns.InMarch2010,SyntaannouncedthattheFDAhadapprovedresumingclinicaldevelopmentofelesclomol,andthattheyexpectedtoinitiateoneormoreclinicaltrialsforelesclomolinthesecondhalfoftheyear.
细胞骨架信号